Jazz Pharmaceuticals JAZZ Payment, Tax Withholding, Share-Based Payment Arrangement
Payment, Tax Withholding, Share-Based Payment Arrangement at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's payment, tax withholding, share-based payment arrangement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's payment, tax withholding, share-based payment arrangement?
- Jazz Pharmaceuticals (JAZZ) reported payment, tax withholding, share-based payment arrangement of $103.6M in Q1 2026.
- How has Jazz Pharmaceuticals's payment, tax withholding, share-based payment arrangement changed year-over-year?
- Jazz Pharmaceuticals's payment, tax withholding, share-based payment arrangement increased by 54.2% year-over-year, from $67.2M to $103.6M.
- What is the long-term trend for Jazz Pharmaceuticals's payment, tax withholding, share-based payment arrangement?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's payment, tax withholding, share-based payment arrangement has grown at a 20.6% compound annual growth rate (CAGR), from $35.6M to $75.22M.
- What does payment, tax withholding, share-based payment arrangement mean?
- Cash paid by the company to tax authorities to cover employee tax obligations from equity compensation.
- How do you interpret payment, tax withholding, share-based payment arrangement?
- Higher payments indicate significant employee equity vesting activity or higher stock prices at the time of exercise.
- How does payment, tax withholding, share-based payment arrangement compare across companies?
- Standard line item for companies with significant stock-based compensation programs.